Text this: Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand

__    __   _    _   __    __    _____    __   _   
\ \\ / // | || | || \ \\ / //  |  ___|| | || | || 
 \ \/ //  | || | ||  \ \/ //   | ||__   | '--' || 
  \  //   | \\_/ ||   \  //    | ||__   | .--. || 
   \//     \____//     \//     |_____|| |_|| |_|| 
    `       `---`       `      `-----`  `-`  `-`